0A6R.L Stock Analysis
0A
Uncovered
Aethlon Medical Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 14 full-time employees. The firm is focused on developing products to diagnose and treat life and organ-threatening diseases. The company is involved in developing the Hemopurifier, a therapeutic blood filtration system indicated for infectious diseases and cancer. The firm operates through two segments: Aethlon and ESI. The Aethlon segment represents its therapeutic business activities. The ESI segment represents its diagnostic business. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seeding the spread of metastasis. The firm is conducting clinical trials in patients with advanced and metastatic head and neck cancer. The company is focused on the treatment of solid tumors that are being treated with checkpoint inhibitors. Hemopurifier have been used to treat individuals infected with human immunodeficiency virus (HIV), hepatitis C virus (HCV), and Ebola.